New York State Governor Kathy Hochul signed a bill formally legalizing and regulating the use of MDMA and psilocybin as official therapeutic practice. However, the bill will take effect only after both substances are certified by federal regulators, which, given the promises of the Sanitary Service and the Ministry of Health, could happen by the end of this year. In addition, the bill also allocates state resources to begin drafting proposed legislation to regulate the production and distribution of these substances.
It is also interesting to note that the bill leaves open the possibility of adding to the list of controlled substances, meaning that if the US authorities accept the legalization of psilocin, or another psychoactive substance, it will also automatically be recognized as a legal therapeutic drug in New York City.
In fact, the bill explicitly refers to the fact that both substances are currently being reviewed and re-evaluated, and are also under active clinical trials in the laboratory of the sanitary service. The authors also note that psilocybin and MDMA are already available to some extent in 23 regions of the country, at least in their limited territory. Formally, the bill recognizes the legality of the production, sale and use of such psychoactive substances by adults, provided that they are recognized as legal drugs by the federal government of the country. Note that similar projects have already been adopted in Colorado, as well as several other regions of the country, also in anticipation of news of an imminent official reform.